Take2 Technologies Limited v. Pacific Biosciences of California, Inc.

Good Law
United States District Court, Northern District of CaliforniaNovember 6, 20235:23-cv-04166California3,832 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION 7 TAKE2 TECHNOLOGIES LIMITED, et Case No. 5:23-cv-04166-EJD al., ORDER GRANTING IN PART Plaintiffs, MOTION TO DISQUALIFY 10 v. Re: ECF No.

PACIFIC BIOSCIENCES OF

CALIFORNIA INC, Defendant. 13 Plaintiffs Take2 Technologies Limited (“Take2”) and the Chinese University of Hong Kong move to disqualify the entire in-house legal department at Defendant Pacific Biosciences of California (“PacBio”). ECF No. 75 (“Mot.”). The Court heard oral arguments on October 26, 2023. Based on the submitted arguments and evidence, the Court GRANTS IN PART Plaintiffs’ motion and ORDERS the parties to meet-and-confer as to the appropriate scope of relief. I. BACKGROUND Prior to August 2022, Ms. Yang Tang was employed as an attorney at Perkins Coie, the law firm that is presently representing Plaintiffs Take2 Technologies Limited (“Take2”) and the Chinese University of Hong Kong. …

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.